- Telephone: +49 421 591355 E-mail: service@biolog.de Literature download
- Telephone: +49 421 591355 E-mail: service@biolog.de Literature download
- Telephone: +49 421 591355 E-mail: service@biolog.de Literature download
Alternative structural projections:
For other salt forms please inquire. Selective and membrane-permeant inhibitor of both cyclic GMP dependent protein kinase I a and I ß and of retinal cGMP-gated ion channels. Resistant against mammalian cyclic nucleotide-dependent phosphodiesterases, no metabolic side effects. More lipophilic and membrane-permeant compared to Rp-8-pCPT-cGMPS (Cat. No. C 013). Detailed technical information and updated reference list available on request. Reference: Butt et. al., Br. J. Pharmacol., 116, 3110 - 3116 (1995).
| Cat. No. | P 007 |
| Patent Information | Protected under patents US 5,625,056 and DE 42 17679 issued to BIOLOG LSI |
| CAS number | [172806-20-1] |
| Purity | > 99% HPLC |
| Salt form | Sodium |
| Storage temperature | -20°C / -4°F |
| Light-sensitive | True |
| Molecular formula | C₁₈H₁₄BrN₅O₆PS · Na |
| Molecular weight [g/mol] | 562,3 |
| Modifications | 1-cGMP, 2-cGMP, 8-cGMP |
| Target | PKG (cGK) Inhibitor |
| Lipophilicity | 2.83 |
| Absorption max [nm] | 256 |
| Molar extinction coefficient ε [L·mol⁻¹·cm⁻¹] | 40000 |
